Higher risk breast screening: cancer detection rates, recall rates, and attendance rates in Northern Ireland. Issue 8 (August 2019)

• Record Type: Journal Article
• Authors: Gibson, E.; Gracey, G.; Ng, C.; O'Neill, T.; Smyth, R.; Rocks, G.; Hall, C.; Briggs, G.; Bane, C.; Bennett, D.; McGuinness, S.
• Is Part Of: Clinical radiology. Volume 74:Issue 8(2019)
• Page Start: 654.e1
• Page End: 654.e5
• Publication Date: 2019-08
• Subjects: Medical radiology -- Periodicals; Radiotherapy -- Periodicals; Radiotherapy -- Periodicals; Radiology -- Periodicals; Societies, Medical -- Periodicals; Medical radiology; Radiotherapy; Electronic journals; Periodicals; 616.0757
• DOI: 10.1016/j.crad.2019.05.002
• Languages: English
• ISSNs: 0009-9260

Abstract

Abstract : AIM: To evaluate the outcomes of higher risk screening in Northern Ireland (NI) and compare with the UK National Health Service Breast Screening Programme (NHSBSP). MATERIALS AND METHODS: Higher risk breast screening commenced in NI in April 2013. Data on the programme were audited retrospectively through the Higher Risk screening centre. As there are no national standards for attendance rates and cancer detection rates, screening data and standards from the NHSBSP were used as a baseline for comparison. RESULTS: Attendance rates for the higher risk screening population have increased each of the last 3 years up to 77.7%. Recall rates have improved year on year from initial 14.2%–8.6%. Cancer detection rates have varied each year with a range from 21.5 per 1, 000 women screened to 30.9 per 1, 000 women screened. CONCLUSION: The Higher Risk Breast Screening Programme in NI represents a success story in risk stratified screening. Performance outcomes are excellent. The data outcomes may be used to inform standards of acceptable practice in the wider NHSBSP. Highlights: The outcomes of higher risk screening in Northern Ireland are evaluated and compared with the NHS Breast Screening Programme. Attendance rates have increased to 77.7%. Recall rates have improved year on year and are now <10%. Over a 4 year period there has been a cancer detection yield of 25.3 per thousand. The data discussed may form the basis for development of targets in this screening programme.